Biopharmaceuticals Market Reports
(18 Reports)
Find the information you need on the biopharmaceutical industry. The Kalorama Information collection of market research reports provides insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth of the US and global biopharmaceutical markets are also featured. You’ll find the latest information on protein therapeutics, generic biologics, and growth factor inhibitors.
|
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable
|
more...
Search inside this report
|
Sep 1, 2009
|
$2,995.00
|
|
The World Market for Biosimilars and the Potential for US Follow-on Biologics
Biosimilars, or generic biologic drugs, are marketed around the world but still restricted in the U.S. This may soon change, and Kalorama Information has released this timely study of the market in Europe and other areas in the world and the possibility of a U.S. Market in the near
|
more...
Search inside this report
|
Aug 1, 2009
|
$3,700.00
|
|
The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with cancer and nearly 7 million people die. The most common cancers affecting the world
|
more...
Search inside this report
|
May 1, 2009
|
$3,995.00
|
|
Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells
|
more...
Search inside this report
|
May 1, 2009
|
$3,995.00
|
|
Stem Cell Therapeutics Markets
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government,
|
more...
Search inside this report
|
Feb 1, 2009
|
$2,500.00
|
|
Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector.
A major factor driving the upward trend in the number of
|
more...
Search inside this report
|
Jan 1, 2009
|
$3,500.00
|
|
Biogenerics: The World Market for Biosimilars
In one sense, the opportunity for follow-on proteins is as good as ever. Some of the biggest-selling biologics developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, have lost patent protection or are set to lose patent protection
|
more...
Search inside this report
|
Apr 1, 2008
|
$3,500.00
|
|
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.
For market-watchers in the pharmaceutical industry, the
|
more...
Buy by the section | Search inside this report
|
Mar 1, 2008
|
$3,995.00
|
|
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market
Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But over the next five years, treatment is going to dramatically change. as detailed in the report Monoclonal Antibodies, Vaccines and
|
more...
Search inside this report
|
May 1, 2007
|
$995.00
|
|
Cell Culture: The World Market for Media, Sera, and Reagents
As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for
|
more...
Search inside this report
|
Jan 1, 2007
|
$4,300.00
|
|
Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 2nd Edition
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector.
The report contains vital market statistics on three main segments of pharmaceutical contract
|
more...
Buy by the section | Search inside this report
|
Sep 1, 2006
|
$3,900.00
|
|
The Protein Therapeutics Market: The Science and Business of a Growing Sector
The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth, competitive market share, geographical segmentation, top products, and forecasts to
|
more...
Buy by the section | Search inside this report
|
Jun 1, 2006
|
$995.00
|
|
Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing
With the mapping of the human genome and the concomitant explosion of proteomics, a steady stream of biopharmaceuticals have been launched—recombinant therapeutic proteins, monoclonal antibody-based products used for therapeutic or in vivo diagnostic purposes, and nucleic acid-based products.
As the rate of regulatory approval for biopharmaceuticals increases, the
|
more...
Buy by the section | Search inside this report
|
Jan 1, 2006
|
$995.00
|
|
The Market for Generic Biologics: Issues, Trends, and Market Potential, 2nd edition
Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over $30 billion
|
more...
Buy by the section | Search inside this report
|
Nov 1, 2005
|
$2,500.00
|
|
The Market for Generic Biologics: Issues, Trends, and Market Potential
Biologics, or biopharmaceuticals, are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biogenerics are not generic biologics, because there can technically be
|
more...
Buy by the section | Search inside this report
|
Jun 1, 2004
|
$1,500.00
|
|
Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline
Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or blocks the ability of cells to divide and multiply. Blood and tissue growth factors have become exciting targets for compounds
|
more...
Buy by the section | Search inside this report
|
Mar 1, 2004
|
$3,500.00
|
|
Growth Factors: Indications, Products, and Markets
Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or, in some cases, blocks the ability of cells to divide and multiply. The nature and mode of action of these
|
more...
Buy by the section | Search inside this report
|
Oct 1, 2003
|
$2,625.00
|
|
Opportunities in Stem Cell Technology
In the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem cell therapies products is very large. This report aims to identify those technologies and opportunities in the United States with the greatest future opportunities, the
|
more...
Buy by the section | Search inside this report
|
Feb 1, 2002
|
$2,625.00
|
|
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
DNA Sequencing Equipment and Services Markets, 2nd Edition
Stem Cell Therapeutics Markets
Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
SNP Genotyping and Analysis Markets
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine)
The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
|